Global Endoscopic Ultrasound (EUS) Needles Market Size By Type (Aspiration Needles (EUS-FNA), Biopsy Needles (EUS-FNB)), By Application (Hospitals, Clinics), By Region, And Segment Forecasts, 2023 to...

The Global Endoscopic Ultrasound (EUS) Needles Market was valued at USD 210 million in 2023 and is projected to reach USD 378 million by 2031, growing at a CAGR of 7.5% during the forecast period of 2023–2031. EUS needles are vital for fine-needle aspiration (FNA) and biopsy procedures, offering a minimally invasive approach for diagnosing gastrointestinal and pancreatic diseases. The growing prevalence of gastrointestinal cancers, advancements in needle design, and increasing adoption of minimally invasive diagnostic techniques are significantly driving market growth. The integration of EUS with advanced imaging and tissue acquisition tools has made these needles indispensable in modern clinical practice.

Drivers:

1. Rising Incidence of Gastrointestinal Diseases:

The increasing global burden of gastrointestinal disorders, including pancreatic and esophageal cancers, is fueling demand for effective diagnostic tools such as EUS-guided FNA and biopsy.

2. Technological Advancements in Needle Design:

Innovation in EUS needle technology—such as improved tip sharpness, flexibility, and core tissue acquisition capabilities—is enhancing diagnostic accuracy and procedural safety.

3. Growth in Minimally Invasive Procedures:

A global shift towards minimally invasive diagnostics and therapeutics, driven by patient preference and lower recovery times, is propelling EUS needle utilization.

Restraints:

1. High Cost of EUS Procedures:

The high cost associated with EUS procedures, particularly in developing economies, poses a barrier to widespread adoption.

2. Limited Access to Skilled Professionals:

A shortage of gastroenterologists trained in EUS techniques limits the deployment of EUS needles, especially in rural and underserved regions.

Opportunity:

1. Expansion in Emerging Healthcare Markets:

The rapid development of healthcare infrastructure and rising awareness of early cancer detection in Asia-Pacific and Latin America offer growth potential for EUS needle manufacturers.

2. Integration with AI-Driven Imaging:

The use of artificial intelligence in endoscopic ultrasound imaging is expected to improve targeting accuracy and procedural outcomes, presenting new avenues for innovation.

Market by System Type Insights:

Based on system type, Fine-Needle Aspiration (FNA) Needles accounted for the largest market share in 2023. FNA needles are widely used due to their ability to collect cytological samples for rapid on-site evaluation (ROSE). Meanwhile, the Fine-Needle Biopsy (FNB) Needles segment is poised for higher growth during the forecast period, driven by their enhanced core tissue retrieval capabilities essential for histopathological analysis.

Market by End-use Insights:

In terms of end-use, Hospitals and Ambulatory Surgical Centers (ASCs) dominated the market in 2023, owing to a high volume of diagnostic procedures and the availability of advanced endoscopic technologies. Specialty Clinics are projected to experience notable growth, particularly in urban centers, due to their increasing specialization in gastrointestinal diagnostics.

Market by Regional Insights:

North America led the global EUS needles market in 2023, supported by high healthcare expenditure, advanced diagnostic infrastructure, and strong reimbursement policies. Asia-Pacific is expected to register the fastest growth through 2031, driven by increasing healthcare investments, growing cancer screening programs, and expanding endoscopic capabilities in countries such as China, India, and South Korea.

Competitive Scenario:

Key players in the Global Endoscopic Ultrasound (EUS) Needles Market include Boston Scientific Corporation, Medtronic plc, Olympus Corporation, Cook Medical LLC, CONMED Corporation, and Steris Endoscopy. These companies are emphasizing R&D investment, regulatory approvals, and strategic collaborations to enhance their market footprint.

Recent Developments:

In 2024, Boston Scientific launched a next-gen EUS-FNB needle with enhanced echogenic visibility and improved sample adequacy.

Olympus Corporation announced in 2023 a collaboration with AI firms to enhance real-time tissue characterization during EUS procedures.

Cook Medical expanded its EUS product line in 2025, introducing a new series of core biopsy needles optimized for pancreatic lesion assessment.

Scope of Work – Global Endoscopic Ultrasound (EUS) Needles Market

Key Market Developments:

2023: Olympus Corporation received FDA clearance for a novel EUS biopsy needle with improved patient safety outcomes.

2024: Medtronic introduced a disposable EUS needle line aimed at infection control and single-use applications.

2025: CONMED Corporation invested in AI-enhanced imaging partnerships for EUS procedure guidance.

FAQs:

1) What is the current market size of the Global Endoscopic Ultrasound (EUS) Needles Market?

The market was valued at USD 210 million in 2023.

2) What is the major growth driver of the Global Endoscopic Ultrasound (EUS) Needles Market?

The rising incidence of gastrointestinal diseases and technological advancements in needle design are major growth drivers.

3) Which is the largest region during the forecast period in the Global Endoscopic Ultrasound (EUS) Needles Market?

North America accounted for the largest market share in 2023, while Asia-Pacific is expected to witness the fastest growth.

4) Which segment accounted for the largest market share in the Global Endoscopic Ultrasound (EUS) Needles Market?

Fine-Needle Aspiration (FNA) Needles held the largest share by system type in 2023.

5) Who are the key market players in the Global Endoscopic Ultrasound (EUS) Needles Market?

Key players include Boston Scientific Corporation, Medtronic plc, Olympus Corporation, Cook Medical LLC, and CONMED Corporation.